Lerouge et al., 2009 - Google Patents
Towards thrombosis-targeted zeolite nanoparticles for laser-polarized 129 Xe MRILerouge et al., 2009
View PDF- Document ID
- 3874489860715685568
- Author
- Lerouge F
- Melnyk O
- Durand J
- Raehm L
- Berthault P
- Huber G
- Desvaux H
- Constantinesco A
- Choquet P
- Detour J
- Smaïhi M
- Publication year
- Publication venue
- Journal of Materials Chemistry
External Links
Snippet
The synthesis and functionalisation of zeolite nanoparticles designed for laser-polarized 129Xe NMR experiments in solution are described. These nanoparticles were functionalized by using original synthesis pathways through semicarbazide COCHO chemistry in order to …
- 239000002105 nanoparticle 0 title abstract description 67
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
- A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lerouge et al. | Towards thrombosis-targeted zeolite nanoparticles for laser-polarized 129 Xe MRI | |
| US6426058B1 (en) | Enhancement of NMR and MRI in the presence of hyperpolarized noble gases | |
| Abou et al. | 89Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer | |
| Botta et al. | Relaxivity enhancement in macromolecular and nanosized GdIII‐based MRI contrast agents | |
| Irure et al. | Sugar/gadolinium-loaded gold nanoparticles for labelling and imaging cells by magnetic resonance imaging | |
| EP2750716B1 (en) | Manganese comprising nanostructures | |
| US20150320890A1 (en) | Nanoparticles for brain tumor imaging | |
| EP3334464B1 (en) | Manganese-based chelate conjugates for molecular mr imaging | |
| Andolina et al. | Analysis of lanthanide complex dendrimer conjugates for bimodal NIR and MRI imaging | |
| Ghobril et al. | A bisphosphonate tweezers and clickable PEGylated PAMAM dendrons for the preparation of functional iron oxide nanoparticles displaying renal and hepatobiliary elimination | |
| Marradi et al. | Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars | |
| Joshi et al. | Multifunctional silica nanoparticles for optical and magnetic resonance imaging | |
| US20180161461A1 (en) | Rare Earth Oxide Particles and Use Thereof in Particular In Imaging | |
| Xiong et al. | Gd-Chelated poly (propylene imine) dendrimers with densely organized maltose shells for enhanced MR imaging applications | |
| Chen et al. | Peptide-functionalized NaGdF 4 nanoparticles for tumor-targeted magnetic resonance imaging and effective therapy | |
| Cabrera-García et al. | Engineered contrast agents in a single structure for T 1–T 2 dual magnetic resonance imaging | |
| Wang et al. | Geometrical confinement directed albumin-based nanoprobes as enhanced T 1 contrast agents for tumor imaging | |
| Carniato et al. | Multifunctional Gd-based mesoporous silica nanotheranostic for anticancer drug delivery | |
| Schühle et al. | Densely packed Gd (III)-chelates with fast water exchange on a calix [4] arene scaffold: a potential MRI contrast agent | |
| US8945512B2 (en) | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for “cest” applications | |
| Chakravarty et al. | A multimeric MRI contrast agent based on a closo-borane scaffold bearing modified AAZTA chelates on the periphery | |
| Tran et al. | One-pot direct synthesis for multifunctional ultrasmall hybrid silica nanoparticles | |
| Chowdhury et al. | Encapsulated or amphiphilic liposomal Fe (III) coordination complexes for MRI studies of tumor uptake and clearance | |
| Costanzo | Development of fluorinated magnetic resonance imaging probes as alternative to gadolinium-based contrast agents | |
| Kulakov et al. | Contrast enhanced MRI of tumors using gadopentetic acid linked to cyclodextrin by an ester bond |